Clinical trial
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to…
NCT00368706 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00368706 |
|---|---|
| Title | A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients |
| Official title | A Randomized, Double-Blind, Paralleled, Active Controlled, Multi-Center Study of the Efficacy and Safety of 5mg Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Bladder, Overactive |
| Intervention type | Drug |
| Interventions | solifenacin succinate, tolterodine |
| Enrollment | 246 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 25, 2006 |
| Last update posted | Apr 10, 2008 |
| Countries | China |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: